Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...
FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...
The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...
Morning Overview on MSN
DeepRare AI beats doctors in rare disease diagnosis test
A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...
Collaboration, partnership, and clinical integration are key.
Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results